Nula Therapeutics, Inc. — Form D
Nula Therapeutics, Inc. of St. Petersburg, FL, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-18. The offering totals $7.4M, of which $7.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-18
- Form: D
- Accession: 0002121301-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.4M
- Amount sold: $7.4M
- Investors: 7
- Date of first sale: 2026-02-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-576919
Issuer
- Name: Nula Therapeutics, Inc.
- CIK: 0002121301
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 961 Arlington Ave N, St. Petersburg, FL, 33705
- Phone: 212-392-4735
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Nils Regge | Director | St. Petersburg, FL |
| Jarod Rutledge | Director | St. Petersburg, FL |
| Christopher Shepard | Director | St. Petersburg, FL |
| Christopher Shepard | Executive Officer | St. Petersburg, FL |
More